|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Net gain on sale of bank-owned property | |||||
| Depreciation of premises and equipment | |||||
| Net amortization of premiums and discounts on debt securities and loans | |||||
| Amortization of intangibles | |||||
| Amortization of terminated cash flow hedge loss | |||||
| Pension plan settlement charge | |||||
| Share-based compensation | |||||
| Tax (expense) benefit from stock option exercises and other equity awards | |||||
| Deferred income tax expense (benefit) | |||||
| Income from bank-owned life insurance | |||||
| Realized losses on securities, net | |||||
| Losses on sale of portfolio loans, net | |||||
| Net gains on loan sales, including changes in fair value | |||||
| Proceeds from sales of loans, net | |||||
| Loans originated for sale | |||||
| (Increase) decrease in operating lease right-of-use assets | |||||
| Increase (decrease) in operating lease liabilities | |||||
| (Increase) decrease in other assets | |||||
| Increase (decrease) in other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of mortgage-backed available for sale debt securities | |||||
| Purchases of other available for sale debt securities | |||||
| Proceeds from sale of mortgage-backed available for sale debt securities | |||||
| Proceeds from sale of other available for sale debt securities | |||||
| Maturities and principal payments of mortgage-backed available for sale debt securities | |||||
| Maturities and principal payments of other available for sale debt securities | |||||
| Net redemptions (purchases) of Federal Home Loan Bank stock | |||||
| Net (increase) decrease in loans | |||||
| Net proceeds from sale of portfolio loans | |||||
| Purchases of loans | |||||
| Proceeds from the sale of property acquired through foreclosure or repossession | |||||
| Purchases of premises and equipment | |||||
| Net proceeds from the sale of bank-owned property | |||||
| Purchases of bank-owned life insurance | |||||
| Proceeds from bank-owned life insurance | |||||
| Proceeds from sale of equity investment in real estate limited partnership | |||||
| Purchase of intangible asset in asset acquisition | |||||
| Equity investment in real estate limited partnership | |||||
| Purchases of other equity investments, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase (decrease) in deposits | |||||
| Proceeds from Federal Home Loan Bank advances | |||||
| Repayment of Federal Home Loan Bank advances | |||||
| Treasury stock purchased | |||||
| Net proceeds from issuance of common stock in public offering | |||||
| Net proceeds from stock option exercises and issuance of other equity awards, net of awards surrendered | |||||
| Cash dividends paid | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Noncash Activities: | |||||
| Loans charged-off | |||||
| Portfolio loans transferred to held for sale | |||||
| Loans transferred to property acquired through foreclosure or repossession | |||||
| Premises and equipment transferred to held for sale | |||||
| Commitment for equity investments in real estate limited partnerships | |||||
| Supplemental Disclosures: | |||||
| Interest payments | |||||
| Income taxes paid, net of refunds | |||||
Loading...
